Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cephalalgia ; 20(6): 588-96, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11075844

RESUMO

In this double-blind study, the efficacy and tolerability of a single dose of almotriptan (6.25 or 12.5 mg) was compared with placebo in the treatment of three consecutive migraine attacks of moderate or severe intensity. Of 1013 randomized patients, 722 evaluable patients completed the study. The total number of attacks relieved (severe or moderate pain reduced to mild or no pain) at 2 h post-dose was significantly higher (P < 0.001) after treatment with almotriptan 6.25 or 12.5 mg compared with placebo (60% and 70% vs. 38%, respectively). Moreover, a consistent response was achieved across and within patients for almotriptan 6.25 or 12.5 mg compared with placebo (pain relief in at least two out of three attacks within 2 h for 64% and 75% vs. 36%, respectively) and less than one-third of the patients relapsed within 24 h. Almotriptan was well tolerated with no significant differences between the almotriptan and placebo treatment groups in the percentage of patients reporting adverse events. Overall, the 12.5-mg dose was associated with the most favourable efficacy/tolerability ratio and is, therefore, the recommended dose.


Assuntos
Analgésicos/uso terapêutico , Indóis/uso terapêutico , Transtornos de Enxaqueca/tratamento farmacológico , Agonistas do Receptor de Serotonina/uso terapêutico , Doença Aguda , Adolescente , Adulto , Idoso , Analgésicos/administração & dosagem , Analgésicos/efeitos adversos , Analgésicos/química , Angiografia Coronária , Relação Dose-Resposta a Droga , Método Duplo-Cego , Eletrocardiografia , Feminino , Humanos , Indóis/administração & dosagem , Indóis/efeitos adversos , Indóis/química , Masculino , Pessoa de Meia-Idade , Estrutura Molecular , Isquemia Miocárdica/induzido quimicamente , Reprodutibilidade dos Testes , Segurança , Agonistas do Receptor de Serotonina/administração & dosagem , Agonistas do Receptor de Serotonina/efeitos adversos , Agonistas do Receptor de Serotonina/química , Fatores de Tempo , Resultado do Tratamento , Triptaminas
2.
Fertil Steril ; 64(1): 179-84, 1995 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7789555

RESUMO

OBJECTIVE: To create an alloplastic spermatocele capable of repeated sperm aspiration. The alloplastic spermatocele has long been a theoretical solution to infertility for those patients with congenital absence of the vas deferens or irreversible obstruction of the male reproductive ductal system. Recent studies have suggested that sperm from efferent ducts are capable of fertilization. Clinical use of alloplastic spermatoceles for collection of epididymal sperm has resulted in unacceptably low pregnancy rates. Improvement in spermatocele function may occur if a microsurgical anastomosis is performed to the epididymis. DESIGN: A newly designed alloplastic spermatocele was implanted in 17 mature male rabbits. The faceplate of the device had a 0.7-mm orifice, allowing direct precise microsurgical anastomosis to a specific loop of the epididymal tubule. RESULTS: Sperm retrieval was possible in 16/17 (94%) animals. Repeated successful aspirations (total of 73) were performed in all but one animal. The total number of sperm collected per spermatocele averaged 115 x 10(6) (range 0 to 734 x 10(6)). The sperm motility varied widely between animals and specimens, with a maximum average of 21.6% motile sperm/aspirate per animal. All spermatoceles eventually occluded (mean time of occlusion 14 days; range 3 to 30 days). The prostheses with the attached epididymides were examined histologically. CONCLUSIONS: This prototype alloplastic spermatocele allows repeated high density sperm retrieval over a short period of time. Low sperm motility may be less problematic clinically as new techniques of IVF become available.


Assuntos
Inalação , Próteses e Implantes , Manejo de Espécimes/instrumentação , Manejo de Espécimes/métodos , Espermatozoides , Animais , Desenho de Equipamento , Estudos de Avaliação como Assunto , Masculino , Plásticos , Coelhos
3.
J Androl ; 15 Suppl: 38S-42S, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7721675

RESUMO

We reviewed the records of 81 consecutive subfertile men with oligospermia and/or asthenospermia, treated for varicocele with either percutaneous embolization or surgical ligation between 1987 and 1991, and compared the outcomes and costs of the two procedures. All men had presented with infertility of at least 6 months duration, and in most cases female factors had been previously evaluated and treated. Patients were offered a choice of embolization or ligation of the internal spermatic vein. Forty-five men (56%) underwent ligation, and 36 men (44%) opted for embolization. The mean age, serum follicle-stimulating hormone, pretreatment sperm density, motility, and concentration of motile sperm were similar for the two groups. Seminal quality improved in 65% of all patients after varicocele ablation (46 of 71). Improvements were seen in postoperative sperm density (P < 0.01), motility (P < 0.002), and concentration of motile sperm (P < 0.001). Thirty-nine percent of the assessable patients established pregnancies during the study interval (26 of 66). The two treatment groups did not differ significantly with regard to the likelihood of postoperative improvement in sperm density (P = 0.64), motility (P = 0.33), concentration of motile sperm (P = 0.11), or pregnancy rate (P = 0.83). Percutaneous embolization and surgical ligation of varicocele are equally effective in improving male infertility and cost about the same. Embolization offers the potential advantage of shorter recovery to full activity as compared to surgical ligation. Where experienced interventional radiologists are available, percutaneous embolization should be offered as an alternative to open ligation.


Assuntos
Embolização Terapêutica , Varicocele/cirurgia , Varicocele/terapia , Adulto , Custos e Análise de Custo , Humanos , Infertilidade Masculina/etiologia , Masculino , Resultado do Tratamento , Varicocele/complicações , Varicocele/economia
4.
Fertil Steril ; 54(1): 121-6, 1990 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2358079

RESUMO

TEST-yolk buffer has been shown to enhance sperm penetration of zona-free hamster eggs. Review of sperm penetration assay (SPA) data from a fertile population was undertaken to determine a normal range for SPA with TEST-yolk buffer enhancement. Thirty-eight intrauterine insemination patients and 4 artificial insemination donors who had successfully initiated a pregnancy within 18 months of SPA analysis were examined. All 42 enhanced SPAs demonstrated penetration of greater than 10%, and 37 of these (88%) yielded SPA values of greater than or equal to 20%. Thirty-three percent (14/42) of these individuals achieved 0% penetration in the SPA without TEST-yolk buffer. The SPA performed with the TEST-yolk modification has fewer false negatives than the assay done with the original methodology.


Assuntos
Bioensaio , Interações Espermatozoide-Óvulo , Trometamina , Animais , Soluções Tampão , Cricetinae , Combinação de Medicamentos , Gema de Ovo , Feminino , Humanos , Inseminação Artificial , Masculino
5.
J Urol ; 134(4): 716-9, 1985 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-4032579

RESUMO

We report 8 patients with end stage renal disease on maintenance hemodialysis who had pyocystis, pyonephrosis or a perinephric abscess. Delay in diagnosis was frequent because the urine-deprived bladder and kidneys were dismissed as potential sites of infection. Treatment of pyocystis with bladder irrigations often was successful and obviated cystectomy. Pyonephrosis or perinephric abscess was a more serious problem and required unilateral nephrectomy.


Assuntos
Abscesso/complicações , Nefropatias/complicações , Falência Renal Crônica/complicações , Pielonefrite/complicações , Doenças da Bexiga Urinária/complicações , Infecções Urinárias/complicações , Idoso , Feminino , Humanos , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Diálise Renal , Supuração , Infecções Urinárias/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...